Introduction {#sec1-1}
============

The hyperglycemic hyperosmolar state (HHS) is a clinical syndrome characterized by increased blood glucose levels and serum osmolality; dehydration, in the absence of serum and urinary ketones; and acidosis.\[[@ref1]\] Although the incidence of HHS is not exactly known, it accounts for about \<1% of hospital admissions because of diabetes.\[[@ref2]\] Usually, HHS presents in elderly individuals with prolonged type II diabetes and has a higher mortality of about 20% compared to \<5% in diabetic ketoacidosis (DKA).\[[@ref3][@ref4][@ref5]\] It can clinically present with symptoms of focal seizures, epilepsia partialis continua (EPC), myoclonus, hemiparesis, hypertonia, and altered sensorium.\[[@ref6][@ref7]\] Early recognition of imaging findings in HHS in those who present with seizures is necessary to avert future complications, initiate prompt management, and reduce mortality.

Characteristic magnetic resonance imaging (MRI) findings in hyperglycemia-induced seizures include focal altered signal intensity, i.e., subcortical T2 hypointensity with gyral hyperintensity involving the cortex and cortical or leptomeningeal postcontrast enhancement.\[[@ref8][@ref9][@ref10][@ref11][@ref12]\] In this study, we present the clinical and MRI findings in six patients with hyperglycemia-induced seizures with a mention of possible underlying pathophysiological mechanisms and review of the literature. We performed a PUBMED search for articles published in English in the database of the National Library of Medicine (NLM) with keywords including "hyperglycemia," "seizures," "nonketotic hyperglycemia," "MRI," and "imaging findings." We included all the studies published with three or more patients describing MRI findings in hyperglycemia-induced seizures after the exclusion of case reports.

Materials and Methods {#sec1-2}
=====================

Study participants {#sec2-1}
------------------

The institute ethics committee of Pushpagiri Institute of Medical Sciences, Tiruvalla, Kerala waived the need for approval due to the retrospective nature of the study. The study group comprised of six consecutive patients with clinical and imaging diagnosis of hyperglycemia-induced seizures in an appropriate clinical setting followed by resolution post-therapy from June 2016 to June 2018 after exclusion of those with an alternate diagnosis on further clinical workup.

The clinical records of the patients were reviewed by an experienced neurologist (RT) for symptoms at presentation, history of diabetes, random blood sugar levels, serum electrolytes (sodium and potassium), blood urea, and HbA1C levels at presentation. The serum osmolality and blood urea nitrogen were calculated as follows,

Serum osmolality *(mOsm/kg = (2x (Na {mmol/L} + K {mmol/L}) + (BUN {mg/dl}/2.8) + (glucose {mg/dl}/18)*

Blood urea nitrogen *(mg/dl) = Urea (mg/dl)/2.14*

Image acquisition {#sec2-2}
-----------------

All the patients underwent MRI on a 1.5 Tesla scanner (Signa HDxt, GE Healthcare, Milwaukee, USA), including conventional sequences (T1 weighted image \[T1W\], T2W, and fluid-attenuated inversion recovery \[FLAIR\]) and advanced sequences (diffusion-weighted imaging \[DWI\] and susceptibility-weighted angiography \[SWAN\]). None of the patients underwent postcontrast T1W/FLAIR imaging.

Image analysis {#sec2-3}
--------------

Two radiologists (AAG and SBH with experience of \>5 years) assessed the MRI findings in hyperglycemia-induced seizures. The regions of the brain involved, and the presence of altered signal intensity of the cortex and subcortical white matter was evaluated on T2W, FLAIR, and SWAN with the presence of restricted diffusion on DWI.

Statistical analysis {#sec2-4}
--------------------

The Statistical Package for the Social Sciences (SPSS) software, version 22 (IBM, Armonk, New York: IBM Corp) was utilized to perform the statistical analysis of all datasets. Descriptive statistics were used for continuous and discrete variables.

The blood levels of random blood sugar and serum osmolality were available in all the included studies and were compared using a one-way analysis of variance (ANOVA) test. Similarly, the signal intensity of subcortical white matter on T2Ws, cortical signal intensity on FLAIR, and DWIs were compared using an independent Chi-square test. *P* \<0.05 was deemed statistically significant.

Results {#sec1-3}
=======

Clinical and demographic characteristics {#sec2-5}
----------------------------------------

The clinical and laboratory findings are as shown in [Table 1](#T1){ref-type="table"}. There were six patients, four males and two females, with age ranging from 60 to 68 years (mean ± standard deviation \[SD\], 63 ± 2.9 years). All patients had type 2 diabetes mellitus (DM), presented with seizures and underwent MRI showing abnormalities. None of the patients had any known etiology for epilepsy other than hyperglycemia. All patients had uncontrolled DM with increased blood glucose levels (range, 385--563 mg/dl; mean ± SD, 500.8 ± 64.2) and glycated hemoglobin (range, 7.2--13.6 mg/dl; mean ± SD, 10.4 ± 2.0). The serum osmolality values were mildly elevated in five patients with normal value in one patient (range, 294--319; mean ± SD, 308.1 ± 8.8). The blood urea nitrogen levels were variable (range, 13--25.7 mg/dl; mean ± SD, 19.2 ± 4.8). Two patients underwent lumbar puncture with normal cerebrospinal fluid (CSF) analysis and showed normal cell counts with no features to suggest bacterial or viral infection. All the patients showed a lack of ketones on urinalysis with elevated urine sugar levels. Two patients underwent electroencephalogram (EEG) with no abnormal ictal discharges.

###### 

Demographics, clinical presentation, and laboratory investigations

  Age/Sex   Clinical presentation                                                                           Blood glucose (mg/dl)   HbA1C (mg/dl)   Na+/K+ (mmol/L)   BUN (mg/dl)   Serum osmolality (mOsm/kg)   Urinary investigations   
  --------- ----------------------------------------------------------------------------------------------- ----------------------- --------------- ----------------- ------------- ---------------------------- ------------------------ -----
  61/M      Left focal motor seizures (Left frontal headache)                                               482                     10.4            132/4.2           15.87         305                          +++                      Nil
  68/F      Right focal motor seizures                                                                      540                     13.6            130/4.5           25.67         308                          +++                      Nil
  64/M      Multiple myoclonic jerks-Right lower limb                                                       563                     7.2             136/3.7           23.8          319                          +++                      Nil
  60/M      Myoclonic jerks in lower limbs (Increased sweating, altered sensorium, slurring of speech)      539                     10.3            136/3.2           20.07         316                          +++                      Nil
  64/M      Generalized tonic clonic seizures (Right hemiparesis)                                           496                     10.9            133/4.5           13.07         307                          ++++                     Nil
  61/F      Right complex partial seizures (Acute onset confusion and disorientation, slurring of speech)   385                     10.2            129/4.3           16.8          294                          +++                      Nil

BUN=Blood urea nitrogen

MRI findings {#sec2-6}
------------

The MRI abnormalities are as shown in [Table 2](#T2){ref-type="table"} and Figures [1](#F1){ref-type="fig"}-[3](#F3){ref-type="fig"}. Cortical hyperintensity was seen in all patients on T2W and FLAIR sequences with restricted diffusion in four patients and the hyperintense cortex on SWAN in two patients. The DWI showed no restriction in two patients with the isointense signal in the cortex in the involved areas. The subcortical T2, FLAIR, and SWAN hypointensity were seen in five patients with the hypointense subcortical white matter on DWI in one patient. The subcortical white matter showed an isointense signal on T2, FLAIR, and SWAN in one patient with isointensity in the subcortical white matter on DWI. There was no evidence of hemorrhage in the involved areas on SWAN. The involvement was predominantly in the posterior cerebral region with parietal involvement in five of six patients (83.3%), followed by occipital in two (33.3%), frontal in two (33.3%), and temporal in two patients (33.3%).

###### 

Summary of MRI findings

  Location involved        Cortex         Subcortical white matter                                              
  ------------------------ -------------- -------------------------- -------------- ------------- ------------- -------------
  Left frontoparietal      Hyperintense   Restriction                Isointense     Hypointense   Isointense    Hypointense
  Left temporoparietal     Hyperintense   Isointense                 Isointense     Hypointense   Isointense    Hypointense
  Right parietooccipital   Hyperintense   Restriction                Isointense     Hypointense   Isointense    Hypointense
  Left parietooccipital    Hyperintense   Isointense                 Hyperintense   Isointense    Isointense    Isointense
  Right frontal            Hyperintense   Restriction                Hyperintense   Hypointense   Hypointense   Hypointense
  Left temporoparietal     Hyperintense   Patchy restriction         Isointense     Hypointense   Isointense    Hypointense

MRI=Magnetic resonance imaging, FLAIR=Fluid attenuation inversion recovery, DWI=Diffusion-weighted imaging, SWAN=Susceptibility-weighted angiography

![Axial T2W (A) FLAIR (B) and SWAN (C) images of the brain show cortical hyper-intensity on T2W, FLAIR, and SWAN images involving right parietooccipital region with adjacent subcortical white matter hypo-intensity](IJRI-29-343-g001){#F1}

![Axial DWI (A) image shows cortical hyper-intensity with corresponding low signal on ADC (B) i.e., restricted diffusion involving the right parietooccipital region](IJRI-29-343-g002){#F2}

![The composite image of FLAIR (A, C, E, G, I and K) and DWI (B, D, F, H, J, and L) showing different locations and imaging findings in six patients as described in [Table 2](#T2){ref-type="table"}](IJRI-29-343-g003){#F3}

Follow-up {#sec2-7}
---------

All the patients were seizure-free after glycemic control and adequate hydration at discharge. The patients were on antiepileptic medication in the period of hospitalization with no further episodes of seizures on follow-up.

Comparison between the various included studies {#sec2-8}
-----------------------------------------------

The analysis of biochemical parameters among various included studies, i.e., random blood sugar and serum osmolality levels were similar as they lacked statistically significant difference as depicted in [Table 3](#T3){ref-type="table"}. Similarly, the MRI findings, i.e., the subcortical T2 signal intensity and cortical signal intensity on DWIs lacked statistically significant difference as depicted in [Table 4](#T4){ref-type="table"}. However, the cortical signal intensity on FLAIR among various included studies showed a statistically significant difference, suggesting variability in the FLAIR signal intensity of the cortex.

###### 

Comparison for biochemical parameters in various included studies

  Study (Year published)        Random blood sugar (mean±SD)   ^a^*P*      Serum osmolality (mean±SD)   b*P*
  ----------------------------- ------------------------------ ----------- ---------------------------- -------
  Seo *et al*. (2003)           418.3±114.8                    0.184       300.8±12.5                   0.198
  Raghavendra *et al*. (2007)   405.5±110.6                    310±5.9                                  
  Chen *et al*. (2011)          416.3±76.9                     300.3±9.4                                
  Lee *et al*. (2016)           391±82.7                       309.9±7.7                                
  Our study (2019)              500.8±64.2                     308.1±8.8                                

^a^*P* for statistical difference between random blood sugar levels between included studies, ^b^*P* for statistical difference between serum osmolality levels between included studies, SD=Standard deviation

###### 

Comparison of MRI findings in various included studies

  Study (Year published)        Subcortical T2 SI   ^a^*P*     Cortical T2 FLAIR SI   ^b^*P*     Cortical DWI SI   ^c^*P*                           
  ----------------------------- ------------------- ---------- ---------------------- ---------- ----------------- ---------- ---------- ---------- -------
  Seo *et al*. (2003)           3 (100)             0 (0)      0.522                  1 (33.3)   2 (66.7)          0.036      1 (33.3)   2 (66.7)   0.094
  Raghavendra *et al*. (2007)   4 (100)             0 (0)      3 (75)                 1 (25)     3 (75)            1 (25)                           
  Chen *et al*. (2011)          5 (83.3)            1 (16.7)   6 (100)                0 (0)      6 (100)           0 (0)                            
  Lee *et al*. (2016)           11 (100)            0 (0)      5 (45.4)               6 (54.6)   4 (36.3)          7 (63.7)                         
  Our study (2019)              5 (83.3)            1 (16.7)   6 (100)                0 (0)      4 (66.7)          2 (33.3)                         

^a^*P* for statistical difference between subcortical T2 signal intensity between included studies. ^b^*P* for statistical difference between cortical T2 FLAIR signal intensity between included studies. ^c^*P* for statistical difference between cortical diffusion-weighted imaging signal intensity between included studies. MRI=Magnetic resonance imaging, SI=Signal intensity, FLAIR=Fluid attenuation inversion recovery, DWI=Diffusion-weighted imaging

Discussion {#sec1-4}
==========

Hyperglycemia-induced seizures are refractory to antiepileptic medications, account for 15--40% of seizures in patients with HHS, and are commonly focal motor seizures and epilepsia partialis continua.\[[@ref13][@ref14]\] Two patients presented with focal motor seizures, two with myoclonic jerks, and one with generalized tonic-clonic seizures and complex partial seizures. It has been documented that, patients with poorly controlled diabetes and high glycated hemoglobin are at increased risk of seizures.\[[@ref9][@ref15][@ref16]\] All the patients in our series, had documented hyperglycemia at presentation, a possible proconvulsant state with elevated HbA1C levels, indicating poorly controlled diabetes of long duration.

A total of four studies (with ≥3 patients) describing MRI findings in hyperglycemia-induced seizures comprising a total of 24 patients were found on PUBMED search in the database of the NLM.\[[@ref11][@ref12][@ref17][@ref18]\] The imaging findings of the patients in previous studies have been described in [Supplementary Table 1](#T5){ref-type="table"}. All the patients in our study showed cortical hyperintensity with restricted diffusion involving 4 of 6 patients (66.6%) compared with cortical hyperintensity in 15 of total 24 patients (62.5%) and restricted diffusion in 14 of 24 patients (58.3%) in previous literature. In our study, 5 of the 6 patients showed subcortical T2 hypointensity with the mild hypointense signal on the SWAN sequence (83.3%) compared with subcortical hypo-intensity seen in 23 of 24 patients (95.8%) in the included studies. The involvement was predominantly in the posterior cerebral regions, i.e., parietal involvement in 83.3% along with frontal, occipital, and temporal involvement in 33.3% patients in our study. Similarly, the posterior cerebral involvement was also predominant in the included studies with occipital involvement being most common (58.3%), followed by parietal (45.8%), temporal (16.6%), and frontal region (16.6%). Postcontrast cortical or leptomeningeal enhancement was reported in 19 of 24 patients (79.2%) in previously published studies.

###### 

Summary and analysis of MRI findings in the selected existing literature

  Study and year published    Location Involved              Cortex         Subcortical white matter   T1/FLAIR Postcontrast Enhancement   
  --------------------------- ------------------------------ -------------- -------------------------- ----------------------------------- ---------
  Seo *et al*. 2003           Left temporal                  Isointense     Normal                     Hypointense                         N/A
  Seo *et al*. 2003           Right occipital                Isointense     Normal                     Hypointense                         N/A
  Seo *et al*. 2003           Left parietooccipital          Hyperintense   Restriction                Hypointense                         Present
  Raghavendra *et al*. 2007   Left temporoparietooccipital   Isointense     N/A                        Hypointense                         Absent
  Raghavendra *et al*. 2007   Left frontal                   Hyperintense   Restriction                Hypointense                         Present
  Raghavendra *et al*. 2007   Right frontal                  Hyperintense   Restriction                Hypointense                         Present
  Raghavendra *et al*. 2007   Left occipital                 Hyperintense   Restriction                Hypointense                         Present
  Chen *et al*. 2011          Right occipitotemporal         Hyperintense   Restriction                Hypointense                         Present
  Chen *et al*. 2011          Right occipitotemporal         Hyperintense   Restriction                Hypointense                         Present
  Chen *et al*. 2011          Left occipital                 Hyperintense   Restriction                Hypointense                         Present
  Chen *et al*. 2011          Right occipital                Hyperintense   Restriction                Hypointense                         Absent
  Chen *et al*. 2011          Left occipital                 Hyperintense   Restriction                Hypointense                         Present
  Chen *et al*. 2011          Right occipital                Hyperintense   Restriction                Hyperintense                        Absent
  Lee *et al*. 2016           Right parietooccipital         Hyperintense   Restriction                Hypointense                         Present
  Lee *et al*. 2016           Right parietal                 Isointense     Normal                     Hypointense                         Present
  Lee *et al*. 2016           Left parietal                  Isointense     Normal                     Hypointense                         Present
  Lee *et al*. 2016           Left parietal                  Isointense     Normal                     Hypointense                         Present
  Lee *et al*. 2016           Left parietooccipital          Hyperintense   Normal                     Hypointense                         Present
  Lee *et al*. 2016           Left parietooccipital          Hyperintense   Restriction                Hypointense                         Present
  Lee *et al*. 2016           Right parietooccipital         Hyperintense   Restriction                Hypointense                         Present
  Lee *et al*. 2016           Left frontal                   Isointense     Normal                     Hypointense                         Present
  Lee *et al*. 2016           Left parietal                  Isointense     Normal                     Hypointense                         Present
  Lee *et al*. 2016           Right frontal                  Isointense     Normal                     Hypointense                         Present
  Lee *et al*. 2016           Left parietal                  Hyperintense   Restriction                Hypointense                         Present

MRI=Magnetic resonance imaging, FLAIR=Fluid attenuation inversion recovery, DWI=Diffusion-weighted imaging

The comparison of biochemical parameters and MRI findings among various included studies suggests similarity in the published literature except for variability in the cortical signal intensity on FLAIR. The variability in FLAIR signal among various studies could be because of differences in the time from ictus to initial MRI and interobserver and scanner variability in the identification of abnormal cortical signal intensity as described in other etiologies.\[[@ref19][@ref20][@ref21]\]

Pathophysiology of seizures and MRI findings {#sec2-9}
--------------------------------------------

The exact pathophysiology leading to seizures in the hyperglycemic hyperosmolar state is not entirely understood. One of the postulated mechanisms is a decrease in the levels of gamma-aminobutyric acid (GABA) because of depression in glucose utilization and Krebs cycle, thereby elevating alternate pathways of glucose metabolism. These metabolic changes lead to the production of succinic acid from GABA using the succinic--semialdehyde pathway, which supplies up to 40% of the energy requirements of brain tissue.\[[@ref7]\] This decrease in the levels of GABA leads to a reduction in the seizure threshold and proconvulsive state. In contrast, diabetic ketoacidosis has an antiepileptic effect as ketone bodies supply most of the energy requirements of neural tissue. Adenosine triphosphate-sensitive potassium channels (K~ATP~) with diminished levels of GABA have been incriminated for the effects of increased extracellular glucose levels leading to neuronal hyperexcitability, neuropropagation, and seizures.\[[@ref22]\]

Although a few studies reported no significant abnormalities in the MRI, subcortical T2 hypo-intensity, cortical hyper intensity with restricted diffusion, and cortical or leptomeningeal postcontrast enhancement, predominantly involving parietooccipital region are characteristic findings reported in hyperglycemia-induced seizures.\[[@ref12][@ref18][@ref23][@ref24]\] Most of the previous studies on MRI changes in peri-ictal period, post generalized tonic-clonic seizures, or status epilepticus reported subcortical T2 hyperintensity and in contrast, most studies reported subcortical T2 hypointensity in hyperglycemia-induced seizures.\[[@ref18][@ref25][@ref26]\] The exact pathophysiology leading to subcortical T2 hypo-intensity is is not known and many hypotheses have been put forward. The transient deposition of free radicals and/or iron because of excitotoxic axonal damage during hyperglycemia-induced seizures and intracellular dehydration in glial and supporting tissues are postulated mechanisms for subcortical altered signal intensity.\[[@ref10][@ref11]\]

In addition to subcortical T2 hypointensity, hyperglycemia -induced seizures are associated with gyriform restricted diffusion and cortical hyperintensity on T2 and FLAIR. Focal hypoxic-ischemic injury with resultant excitotoxic damage and mitochondrial dysfunction during epileptogenic activity lead to the failure of Na^+^/K^+^ ATPase pump, cellular swelling, and cytotoxic edema.\[[@ref25]\] Cytotoxic edema along with hyperperfusion and vasogenic edema results in restricted diffusion and cortical hyperintensity on T2 and FLAIR imaging.\[[@ref27][@ref28][@ref29]\] Cortical or leptomeningeal postcontrast enhancement could be because of increased perfusion and vascular permeability resulting in loss of blood--brain barrier (BBB) in response to the hypermetabolic state during epileptic activity.\[[@ref27][@ref28][@ref29]\]

The posterior predilection of involvement in hyperglycemia-induced seizures could be attributed to sympathetic dysautonomia, endothelial damage, and dysfunction leading to altered cerebrovascular reactivity secondary to long-standing diabetes. The regions of involvement are akin to posterior reversible encephalopathy syndrome (PRES) although imaging manifestations differ.\[[@ref30]\]

There are many clinical pathologies associated with subcortical T2 hypointensity other than hyperglycemia-induced seizures, including infectious etiologies, such as meningitis and viral encephalitis; hypoxic-ischemic events, such as hemorrhagic infarct and hypoxic insult; and neoplastic etiology, such as leptomeningeal metastasis.\[[@ref31][@ref32]\] The leptomeningeal enhancement is seen in infectious causes, such as bacterial, viral, and fungal meningitis and neoplastic causes, such as carcinomatous meningitis. Cortical enhancement is observed in vascular causes, such as post-ischemic vasodilatation, seizures, PRES, and migraine, and infectious causes, such as meningitis and encephalitis.\[[@ref33][@ref34]\] Although myriad etiologies present with subcortical T2 hypointensity, cortical hyperintensity, and postcontrast leptomeningeal or cortical enhancement, seizures at initial presentation in the clinical setting of uncontrolled hyperglycemia, hyperosmolar state, and absence of ketone bodies should suggest the possibility of hyperglycemia-induced seizures.

The current study has a few limitations. First is the modest sample size in our study and the included studies and their retrospective nature limiting extrapolation of the findings to the general population. This necessitates a prospective study with a large sample size to address the issue. Second, the inability to compare postcontrast sequences among the included studies because of lack of contrast-enhanced sequences in our study group. Third, the investigations to rule out all the possible etiologies causing subcortical T2 hypointensity were not performed in all patients because of clinical background at presentation. However, seizure-free course after adequate therapy leaves no scope for alternate diagnosis. Fourth, the lack of follow-up imaging limits the assessment for reversible nature of the imaging findings. Lastly, inability to compare all the biochemical investigations and imaging findings included heterogeneity in the data among the studies.

Conclusion {#sec1-5}
==========

Our study highlights the presence of posterior predominant subcortical T2, FLAIR, and SWAN hypo-intensity; cortical hyper intensity; and restricted diffusion in hyperglycemia-induced seizures. The awareness of MRI findings in hyperglycemia-induced seizures may facilitate early diagnosis, prevent misdiagnosis and inadvertent invasive workup, and further facilitate the timely administration of appropriate management, as they are usually drug-resistant and respond only after control of elevated blood glucose levels.

Main Points {#sec1-6}
===========

There are myriad etiologies that can present with subcortical T2 hypo signal, including infectious etiologies, such as meningitis and viral encephalitis; hypoxic-ischemic events, such as hemorrhagic infarct and hypoxic insult; and neoplastic etiology, such as leptomeningeal metastasis along with hyperglycemia-induced seizuresSeizures at initial presentation in the clinical setting of uncontrolled hyperglycemia, hyperosmolar state, and absence of blood and urinary ketones along with subcortical T2 hypo-intensity most likely represents hyperglycemia-induced seizures. Awareness of this entity helps avoid misdiagnosis, inadvertent invasive workup and initiate appropriate managementAlthough the posterior predominant involvement is hypothesized, analysis of pooled data suggests the presence of the anterior involvement, i.e., signal changes in frontal and temporal lobes are not uncommonThe observation of variability in cortical FLAIR signal in the pooled data could possibly be attributed to the differences in the time from ictus to initial MRI, inter-observer, and scanner variability in identification of abnormal cortical signal, which has also been described in other etiologies.
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